Mined Therapeutics
Cambridge, US · Founded 2021 · Massachusetts corporation · 1 known investors
Founders & leadership
AS
ANDREW SANDFORDNamed on SEC filing
AK
ALEX KOGLINNamed on SEC filing
TN
THOMAS NICKOLOFFNamed on SEC filing
Board
DS
Investors · 1
Reported raises · per SEC filings
Form D private placements$7M disclosed across 1 round · 2021
▶$7MraisedSep 2021 · 18 investors · BiotechnologyRule 506(b)
▶$7MraisedSep 2021 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ANDREW SANDFORDExecutive Officer, Director
- DAVID SELDINDirector
- ALEX KOGLINDirector
- THOMAS NICKOLOFFDirector
- Offering amount
- $7M
- Amount sold
- $7M
- First sale
- Sep 2021
- Incorporated
- Corporation, Massachusetts, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Mined Therapeutics's investors?
- Mined Therapeutics's investors include Anzu Partners.
- How much funding has Mined Therapeutics raised?
- Mined Therapeutics has disclosed $7M raised across 1 round.
- Where is Mined Therapeutics headquartered?
- Mined Therapeutics is headquartered in Cambridge, US.